Semaglutide is the active ingredient in the popular new weight-loss and diabetes drugs Wegovy and Ozempic, and a large new study has found that it dramatically reduces the risk of an Alzheimer’s diagnosis over three years. Plus, the types of patients So, who benefits the most?
